Management of the dysfunctional and neurogenic bladder: Myths and reality Edward J. McGuire Invited Commentary Pages: 429 - 430
Antimuscarinic therapy in men with bladder outlet obstruction David R. StaskinSteven A. KaplanAlan J. Wein Clinical Trials Report Pages: 437 - 439
Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis Emmanuel GrahamToby C. Chai OriginalPaper Pages: 440 - 446
The bladder epithelium and overactive bladder: What we know Courtenay K. MooreHoward B. Goldman OriginalPaper Pages: 447 - 449
Frequency, urgency, and pelvic pain: Treating the pelvic floor versus the epithelium Kenneth M. PetersDonna J. Carrico OriginalPaper Pages: 450 - 455
Refractory overactive bladder in men: Update on novel therapies Casey K. NgRicardo R. GonzalezAlexis E. Te OriginalPaper Pages: 456 - 461
Antimuscarinic therapy in men with lower urinary tract symptoms: What is the evidence? Roger Dmochowski OriginalPaper Pages: 462 - 467
Effects of testosterone on cognition and mood in male patients with mild Alzheimer’s disease and elderly men Culley C. Carson Clinical Trials Report Pages: 471 - 472
Treatment of premature ejaculation: new drugs and treatment strategies Wayne J. G. HellstromJay W. Heintz OriginalPaper Pages: 473 - 478
Current use of penile implants in erectile dysfunction John J. MulcahySteven K. Wilson OriginalPaper Pages: 485 - 489
Erectile dysfunction and cardiac disease: Recommendations of the second princeton conference Raymond C. RosenGraham JacksonJohn B. Kostis OriginalPaper Pages: 490 - 496
Priapism: New concepts in the pathophysiology and new treatment strategies Trinity J. BivalacquaArthur L. Burnett OriginalPaper Pages: 497 - 502